Table 4 Additional Elixhauser comorbidity measures inferred from drug prescribing information (N = 247,712)
Comorbidities | Claim data1(A) | Prescribing information2(B) | Claim data ∩ Prescribing information3(A∩B) | Fraction of additional comorbidities inferred by prescribing information {(A∪B)-A}/(A∪B) |
|---|---|---|---|---|
Peripheral vascular disorders | 6,707 | 21,858 | 2,452 | 74.3% |
Psychoses | 1,719 | 4,614 | 1,420 | 65.0% |
Chronic pulmonary disease | 26,038 | 36,129 | 16,517 | 43.0% |
Congestive heart failure | 5,423 | 4,159 | 1,419 | 33.6% |
Deficiency anemia | 12,518 | 12,949 | 6,927 | 32.5% |
Depression | 8,267 | 4,420 | 2,134 | 21.7% |
Other neurological disorders | 7,037 | 2,900 | 1,491 | 16.7% |
Hypothyroidism | 5,346 | 2,792 | 1,909 | 14.2% |
Renal failure | 4,952 | 1,054 | 400 | 11.7% |
Weight loss | 7,445 | 556 | 130 | 5.4% |
AIDS | 35 | 10 | 8 | 5.4% |
Cardiac arrhythmia | 10,310 | 975 | 646 | 3.1% |
Rheumatoid arthritis/ collagen vascular diseases | 3,530 | 144 | 73 | 2.0% |
Liver disease | 21,051 | 255 | 187 | 0.3% |